Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,400 public trials 1,995 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, not recruiting

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

NCT03701334

Conditions
Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
Locations
  • University of Alabama at Birmingham-Kirklin Clinic Birmingham, Alabama, United States
  • Cancer Treatment Centers of America Goodyear, Arizona, United States
  • St Bernards Medical Center Jonesboro, Arkansas, United States
  • Comprehensive Blood and Cancer Bakersfield, California, United States
View all 386 locations
View Trial Details
Active, not recruiting

Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

NCT03939897

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
View all 14 locations
View Trial Details
Active, not recruiting

Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.

NCT03616587

Conditions
Breast Diseases, Breast Neoplasms, ER+ HER2- Advanced Breast Cancer, +4 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Philadelphia, Pennsylvania, United States
  • Research Site Nashville, Tennessee, United States
View all 17 locations
View Trial Details
Active, not recruiting

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

NCT02955940

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • University of Louisville Louisville, Kentucky, United States
  • New York Oncology Hematology Pc. Clifton Park, New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

NCT04546009

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Orange Coast Memorial Medical Center Fountain Valley, California, United States
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • Kaiser Permanente - San Leandro Medical Center San Leandro, California, United States
  • Stanford Univ Medical Center Stanford, California, United States
View all 255 locations
View Trial Details

Related conditions